癌症患者的COVID-19:基线影像学严重程度与早期演变能否预测临床结局?
回顾性研究纳入627例COVID-19阳性癌症患者,其中248例在诊断72小时内行基线胸片,64例在72小时内复查。基线胸片异常与住院、插管、死亡相关;基线严重程度评分越高,不良结局可能性越大;早期影像学进展与不良结局无相关性。
要点
- 癌症患者COVID-19诊断72小时内胸片异常与住院、插管、死亡相关。
- 基线严重程度评分>9预测插管概率>50%,评分≥10预测死亡概率>50%。
- 早期影像学进展与住院、插管、死亡无相关性。
核心结论
- 癌症患者COVID-19诊断72小时内胸片肺实质受累程度与不良结局相关,早期影像学进展与不良结局无相关性。
研究设计与样本
- 回顾性研究,627例COVID-19阳性患者(2020年3月至4月),其中248例有诊断72小时内基线胸片,64例有72小时内随访胸片;胸片分为异常、正常或不确定,异常胸片按肺区域计算基线和随访严重程度评分。
关键影像表现/征象
- 248例基线胸片患者中172/248(69%)基线胸片异常。
- 基线严重程度评分中位数3(范围1-10)。
诊断标准与关键数值
- 基线胸片异常与住院(p<0.001)、插管(p=0.001)、死亡(p=0.005)相关。
- 实体肿瘤患者校正分期后,基线胸片异常与住院(p=0.0002)、插管(p=0.019)、死亡(p=0.03)相关。
- 基线严重程度评分越高,不良结局可能性越大(所有p<0.003)。
- 基线严重程度评分>9预测插管概率>50%,评分≥10预测死亡概率>50%。
临床应用与阅片要点
- 癌症患者COVID-19诊断72小时内胸片异常及较高基线严重程度评分提示不良结局风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine whether the degree of parenchymal involvement on chest radiograph (CXR) at the time of COVID-19 diagnosis and its early radiologic evolution can predict adverse events including hospitalization, intubation, and death in patients with cancer.
METHODS: Retrospective study of 627 COVID-19-positive patients between March and April 2020, of which 248 had baseline CXR within 72 h of diagnosis and 64 patients had follow-up wihtin72 h. CXRs were classified as abnormal (i.e., radiologic findings suggestive of COVID-19 infection were noted), normal, or indeterminate. Baseline and follow-up severity scores were calculated based on lung regions in abnormal CXRs. Statistical analysis was performed to determine associations between abnormal CXR or severity score with adverse events.
RESULTS: Of 248 patients (median age = 65) with a baseline CXR, 172/248 (69%) had an abnormal baseline study, which was associated with hospitalization (p < 0.001), intubation (p = 0.001), and death (p = 0.005). For patients with solid neoplasms, when adjusted for stage, it was associated with hospitalization (p = 0.0002), intubation (p = 0.019), and death (p = 0.03). The median baseline severity score was 3 (range = 1-10); the greater the score, the higher the likelihood of adverse outcome (p < 0.003 for all). A baseline severity score > 9 predicted > 50% probability of intubation and a score of ≥ 10 predicted > 50% of probability of death. The baseline severity score was not correlated with cancer-related treatment. Early radiologic progression was not correlated with hospitalization, intubation, or death.
CONCLUSION: The degree of parenchymal involvement on CXR within 72 h of COVID-19 diagnosis is associated with adverse outcomes in patients with cancer.
KEY POINTS: • In patients with cancer, the presence and severity of radiologic manifestation of COVID-19 on chest radiographs within 72 h of COVID-19 diagnosis are associated with hospitalization, intubation, and death. • Early radiologic progression on chest radiographs is not correlated with adverse outcomes.
引用
- Perez-Johnston R, Araujo-Filho J, Mckenney AS, et al. COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes? Eur Radiol. 2021. PMID: 34718846. doi:10.1007/s00330-021-08341-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。